TITLE

FROM THE ANALYST'S COUCH: Obesity market overview

AUTHOR(S)
Farrigan, Christine; Pang, Kevin
PUB. DATE
April 2002
SOURCE
Nature Reviews Drug Discovery;Apr2002, Vol. 1 Issue 4, p257
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents an overview of available pharmacological therapies for obesity. Sibutramine; Axokine; Bupropion; Recombinant human leptin; Topiramate; Forecast of sales of antiobesity agents by 2010.
ACCESSION #
9061406

 

Related Articles

  • Is immediate-release topiramate an effective treatment for adult obesity? Harshman, Heather; Kovach, Fran // Journal of Family Practice;Dec2014, Vol. 63 Issue 12, p745 

    The article provides an answer to a question on how effective immediate-release topiramate can treat obesity in adults.

  • Topiramate: An effective add-on treatment in obese, drug-naïve patients with type 2 diabetes.  // Formulary;Sep2007, Vol. 42 Issue 9, p560 

    The article reports on the result of a study which demonstrated topiramate as an effective add-on treatment to lifestyle changes in obese patients with type 2 diabetes in the U.S. The use of topiramate was also associated with significant reductions in weight, blood pressure and urinary albumin...

  • SIBUTRAMINE. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p752 

    The article presents information on sibutramine, an appetite suppressant, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • SIBUTRAMINE.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2007, p758 

    The article presents information on sibutramine, an appetite suppressant used for the treatment of obesity and maintenance of weight loss. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible...

  • SIBUTRAMINE.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2008, p756 

    The article presents information on sibutramine, an appetite suppressant used for the treatment of obesity and maintenance of weight loss. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible...

  • Controversy about the Cardiovascular Safety of Sibutramine. Scheen, André J. // Drug Safety;2010, Vol. 33 Issue 7, p615 

    In this article, the author discusses the cardiovascular safety of sibutamine as the cure of obesity. He agrees that conventional risk-reduction measures such as the use of aspirin and lipid-lowering drugs are proven effective in reducing cardiovascular diseases (CVD) and saving lives of at-risk...

  • Chapter 2: Isn't There Anything to Keep Me from Being So Hungry All the Time? Hunter, William // When Dieting Isn't Enough: Medications & Surgeries for Weight Lo;2005, p31 

    This article provides information on the classes of drugs used to treat obesity that reduces hunger. For the most part, chemical substances within the body control hunger. The body produces them in response to the cues such as the amount of sugar in the bloodstream. Most of the drugs that work...

  • Reductil.  // Royal Society of Medicine: Medicines;2002, p470 

    This article presents information on Reductil, a proprietary preparation of the appetite suppressant sibutramine. It can be used to assist in obesity treatment, and is available in capsules.

  • Sibutramine.  // Reactions Weekly;3/14/2009, Issue 1243, p40 

    The article presents a case study of a 27-year-old woman with bipolar I disorders who had been asymptomatic for 18 months while receiving carbamazepine and risperidone. The patient started receiving sibutramine for obesity. She presented with irritability, increased energy and frenzied activity...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics